All In Biotech

Free tool

FAERS Monitor: Braftovi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210496 or its brand name (Braftovi, Encorafenib). Reports on generic versions are filed under their own applications.

Reports

10,191

Serious

7,170

70% of reports

Hospitalization

2,833

Death reported

1,700

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,201
  • off label use1,142
  • nausea872
  • fatigue795
  • diarrhoea652
  • pyrexia615
  • neoplasm progression553
  • product use in unapproved indication523
  • vomiting488
  • rash486
  • serous retinal detachment360
  • arthralgia329
  • decreased appetite320
  • malaise306
  • malignant neoplasm progression280

Reports by year received

View as table
YearReports
20171
2018245
20191,312
20201,380
20211,146
20221,327
20231,390
20241,218
20251,239
2026933

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,968 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
serous retinal detachmentSignal3601555.21358.3318,069
neoplasm progressionSignal55333.330.717,071
malignant neoplasm progressionSignal2805.75.01,071
product use in unapproved indicationSignal5234.44.01,365
pyrexiaSignal6153.73.41,211
deathSignal1,2012.92.71,532
decreased appetiteSignal3202.82.6385
off label useSignal1,1422.72.61,266
rashSignal4862.32.1364
nauseaSignal8722.32.1646
vomitingSignal4882.12.0303
fatigueSignal7952.12.0480
diarrhoeaSignal6522.11.9379
arthralgia3291.61.582
malaise3061.41.342

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.